We have transferred the lpr gene from the MRL-lpr mice onto the C57BL/6J background by eight cycles of cross-intercross mating. We found that, like MRL-lpr mice, C57BL/6J-lpr/lpr (B6-1pr) mice develop an autoimmune disease characterized by lymphadenopathy, antinuclear antibodies, and early mortality. Moreover, they lose the ability to produce and respond to IL-2. In contrast, control C57BL/6J-+/+ (B6-+/+) mice lacking the lpr gene have normal IL-2 production and response. These findings suggest that homozygosity at the lpr locus results in both autoimmunity and deficiency of IL-2 activity. Our results further suggest that IL-2 deficiency may contribute to the immunoregulatory abnormalities that underlie murine lupus.
Materials and Methods
Mice. MRL-lpr, MRL/Mp-+/+ (MRL-+/+), and B6-lpr breeding pairs were obtained from The Jackson Laboratory, Bar Harbor, Maine, and were maintained at the University of California, San Francisco Vivarium, and the Veterans Administration Medical Center, San
Francisco. MRL-lpr and MRL-+/+ are congenic strains with 99.6% genetic homology. MRL-+/+ mice lack the autosomal recessive gene responsible for accelerated autoimmunity and lymphoproliferation in MRL-lpr mice (1) .
Culture Medium. RPMI 1640 medium (Cell Culture Facility, University of California, San
Francisco, Calif.) was supplemented with 10% heat-inactivated fetal calf serum (Sterile Systems, Inc., Logan, Utah), 1 mM glutamine, 0.1 mM nonessential amino acids, 1 pM sodium pyruvate, 100 U/ml penicillin, 100 #g/ml streptomycin, 50 #g/ml gentamycin, and 5 × 10 -s M 2-mercaptoethanol. This medium was used in the production and testing of IL-2.
IL-2 Production. Spleen cells were suspended at a density of 1 × 10/ml in culture medium supplemented with 10/~g/ml concanavalin A (Con A; Miles Laboratories, Inc., Elkhart, Ind.). The cells were incubated in Falcon 3008 multiwell tissue culture plates (Falcon Labware, Oxnard, Calif.) for 36 h at 37°C in a humidified atmosphere containing 5% CO2. These conditions are optimal for production of IL-2 by murine spleen cells (21) . Cells were removed from the culture supernatants by centrifugation at 1,500 g for 10 min. Cell-free supernatants were subsequently passed through 0.22-/~m filters (Millipore Corp., Bedford, Mass.) and stored at -20°C.
IL-2 Assay. IL-2 activity was measured using a slight modification of the technique of Smith et al. (22) . Normal spleen cells were cultured for 48 h with Con A (2 /~g/ml) and subsequently washed three times in 10 mg/ml a-methyl-v-mannoside (Sigma Chemical Co., St. Louis, Mo.). The cells were then incubated in 96-well microtiter plates (Linbro Scientific, Inc., Hamden, Conn.) with serial dilutions of the culture supernatant being tested for IL-2 activity. Each well contained 5 × 103 cells in a volume of 200/tl. Cultures were supplemented with 10 mg/ml a-metbyl-D-mannoside to block the possible mitogenic effects of Con A in the test samples. They were maintained at 37°C in a humidified atmosphere of 5% CO2. 1 /~Ci of [3H]thymidine added during the last 24 h of a 72-h incubation yielded optimal thymidine incorporation. The cultures were then harvested onto glass fiber filter strips, and retained radioactivity was measured in a Packard liquid scintillation counter (Packard Instrument Co., Downers Grove, Ill.).
In preliminary experiments, it was determined that spleen cells from MRL-+/+, B6-+/+, and DBA/2 mice proliferated comparably in response to IL-2. Therefore, we used MRL-+/+ spleen cells in our assay of IL-2 activity.
IL-2 Response. The assay described above was also used to determine the ability of MRL-lpr spleen cells to respond to IL-2. This was accomplished by incubating Con A-activated MRL-lpr spleen cells with supernatants known to contain IL-2. The preparation of partially purified human IL-2 (Associated Biomedie Systems, Inc., Buffalo, N. Y.) used in these experiments has been described previously (23) .
IL-2 Absorption. Fresh spleen cells from MRL-lpr and MRL-+/+ mice were stimulated with Con A (2 #g/ml) for 48 h, washed three times in a-methyl-n-mannoside (10 mg/ml), and incubated with a standard IL-2 preparation (5 × 107 cells/ml) for 2 h at 37°C. After incubation, the cells were removed by centrifugation at 1,500 g for 10 min, and the remaining supernatants were tested for IL-2 activity.
Interleukb2 1 (IL-1) Production. The IL-1 used in these experiments was generously provided by Dr. Robert Mishell of the University of California at Berkeley. Briefly, macrophage culture supernatants were derived from PU5-1.8 cells as described previously (24) and tested for IL-1 activity in the thymocyte proliferation assay of Farrar et al. (25) . Culture supernatants retained 50% maximum activity in the IL-1 assay at a 1:32 dilution.
Results

IL-2 Production by MRL-lpr Spleen Cells. MRL-lpr mice had a marked defect in IL-
2 production that was already prominent early in life and increased with age ( Fig. 1 ).
Culture supernatants derived from 2-mo-old MRL-lpr mice had relatively little IL-2 activity even at the highest concentration tested (1:2), and had no activity beyond a 1:4 dilution. In contrast, culture supernatants derived from age-matched MRL-+/+ mice retained activity through a 1:64 dilution ( Fig. 1 a) . By 5 mo of age, the defect in IL-2 production was virtually absolute (Fig. 1 b) . The reduction in IL-2 activity was independent of the duration of culture or the dose of Con A used (Fig. 2) . can be replaced in vitro by either phorbol myristic acetate (PMA) or the macrophage product, IL-1 (26) . To determine whether IL-2 deficiency in MRL-lpr mice reflects a macrophage defect rather than a primary T cell defect, we supplemented our cultures with these macrophage-replacing factors. Neither PMA nor IL-1 stimulated IL-2 production by Con A-activated MRL-lpr spleen cells, although they did enhance IL-2 production by control MRL-+/+ spleen cells (Fig. 4) . Peak IL-2 production by MRL-+/+ spleen cells was associated with 10 ng/ml PMA or a 1:10 dilution of our IL-1 preparation. MRL-lpr spleen cells failed to produce IL-2 at PMA concentrations ranging from 5 to 20 ng/ml and IL-1 dilutions ranging from 1:9 to 1:32. Neither PMA nor IL-1 stimulated IL-2 production in the absence of Con A, nor did PMA or IL-1 cause significant thymidine incorporation in the IL-2 assay (data not shown).
Effect of MRL-lpr Spleen Cells on IL-2 Production by MRL-+ / + Spleen
Pathologic Features and IL-2 Production in B6-lpr Mice.
The characteristics of B6-1pr mice are summarized in Table I . B6-lpr mice had the typical features of disease seen in MRL-lpr mice: lymph nodes were increased in size 10-20-fold by 4 mo of age;
antinuclear antibodies were present at 6 mo of age; and the median survival was response to Con A, spleen cells from 3-mo-old mice showed a marked reduction in IL-2 activity (Fig. 5) . There was virtually no IL-2 activity at 6 mo of age.
Spleen Cell Response to IL-2.
Con A-stimulated spleen cells from MRL-lpr and B6-lpr mice proliferated significantly less in response to standard IL-2 preparations than did spleen cells from age-matched controls (Table II) . Like the defect in IL-2 production, the defect in IL-2 response was present in 2-mo-old MRL-lpr mice (P <0.05; t test for comparison of two independent means) and rose dramatically by 5 mo of age (P <10-5).
Absorption of lL-2 Activity by Activated T Cells.
The failure of MRL-lpr spleen cells to respond normally to IL-2 suggested that they might be unable to bind the lymphokine. To investigate this possibility, we incubated a standard IL-2 preparation with Con A- B6-lpr (6- activity had been removed from the supernatant (Fig. 6) . In contrast, incubation with MRL-lpr cells removed very little, if any, IL-2.
Discussion
Culture supernatants derived from Con A-activated MRL-lpr but not MRL--I-/+ spleen cells were deficient in IL-2 activity. In addition, MRL-lpr spleen cells responded poorly to IL-2. These defects were present early in life and became nearly absolute by 5 mo of age. These findings suggest that deficient IL-2 activity may contribute to impaired immunoregulation and to the development of autoimmune disease. Because MRL-lpr and MRL-+/+ mice are congenic strains, we suspected that the lpr gene might code for a product that directly or indirectly caused deficient IL-2 activity and impaired immunoregulation. This hypothesis was supported by our finding that C57BL/6J mice bearing the lpr gene also developed early IL-2 deficiency and subsequently a lupus-like illness. Thus, in two mouse strains, the lpr gene is associated with both IL-2 deficiency and autoimmune disease.
We considered several mechanisms through which IL-2 deficiency might arise. Because production of IL-2 is macrophage dependent (26), a macrophage defect could result in decreased IL-2 production. Our observation that neither IL-1 nor PMA restored IL-2 production in MRL-lpr mice suggests that IL-2 deficiency is not due solely to a macrophage defect. In humans, Con A induces suppressor cells that suppress IL-2 production (27). We found no such suppressor cells in MRL-lpr mice, nor did MRL-lpr mice produce a soluble inhibitor of IL-2 activity.
A structural abnormality might produce an IL-2 molecule lacking biological activity. However, this would not easily explain the increasing severity of IL-2 deficiency with age. Alternatively, spleen cells capable of producing IL-2 may be diminished in frequency due to proliferation of other lymphocyte subpopulations. We doubt that an alteration in cell ratios is solely responsible for the IL-2 deficiency because this defect is present in young MRL-lpr mice in whom lymphoproliferation is mild. Furthermore, the proliferating cells in MRL-lpr mice are Lyt-1+23 -(3), as are the cells that normally produce IL-2 (28) .
Two signals are necessary for normal lymphocytes to proliferate in response to IL-2 (22, 29) . First, they must be stimulated by mitogen or antigen because receptors for IL-2 are expressed on activated T cells but not on resting T cells. Second, they must be stimulated by IL-2. We have shown that Con A-stimulated MRL-+/+ spleen cells can absorb IL-2, whereas Con A-stimulated MRL-lpr spleen cells cannot. These findings imply that the poor response of MRL-lpr spleen cells in the IL-2 assay reflects an actual or functional deficiency of surface receptors for IL-2. The relationship between the defect in production of IL-2 and the defect in generation of IL-2 receptors is a problem for further study. However, it does not appear that these defects simply reflect a generalized failure of Con A-stimulated responses because certain Con Ainduced functions, such as cellular suppression of immunoglobulin synthesis (5), are normal even in old MRL-lpr mice.
The relationship between IL-2 deficiency and autoimmunity is intriguing. Normal immunoregulation depends upon a complex set of cellular interactions (30) in which IL-2 appears to play an important role (14) (15) (16) (17) (18) . IL-2 stimulates thymocyte proliferation (14, 15) , provides helper activity for antibody production (14) (15) (16) , and facilitates the induction of cytotoxic T cells (14) (15) (16) (17) (18) . Diminished IL-2 production might alter vital immune functions and thereby contribute to autoimmunity. Indeed, the depressed SMLR, which is considered to be a model for abnormal cellular interaction in autoimmune mice (10, 11) , may be due to the deficiency of IL-2. There is a temporal correlation between the disappearance of IL-2 activity and the loss of syngeneic reactivity in MRL-lpr mice. Both occur early in life, before the onset of overt clinical disease. The defective cell in the SMLR bears the Lyt-1+23 -phenotype characteristic of IL-2-producing cells (11, 28) . It has recently been shown that IL-2 is produced in the course of a normal SMLR (13) . Its absence could contribute to the abnormal SMLR of MRL-lpr mice.
The coexistence of T cell proliferation and reduced IL-2 activity in MRL-lpr mice may appear paradoxical. However, it is possible that controlled proliferation of Lyt-I+23 -T cells requires IL-2-dependent T cell differentiation. Uncontrolled proliferation of Lyt-l÷23 -T cells might then arise as a consequence of IL-2 deficiency.
Alternatively, the stimulus for lymphoproliferation in MRL-lpr mice may be IL-2 independent. The observation that IL-2 deficiency precedes the onset of overt autoimmune disease in two strains bearing the lpr gene (MRL, C57BL/6J) raises the possibility that the lpr mutation is causally related to murine lupus through defective T cell regulation arising as a consequence of the IL-2 abnormality.
Summary
Spleen cells from MRL-lpr and B6-lpr mice have a marked defect in the ability to produce interleukin 2 (IL-2) in response to concanavalin A stimulation. This defect precedes the onset of clinical illness, increases with age, and eventually becomes virtually absolute. It is not due to cellular suppression of IL-2 production, nor does it reflect the presence of a soluble inhibitor of IL-2 activity. Failure to restore IL-2 production with macrophage-replacing factors, such as interleukin 1 and phorbol myristic acetate, suggests that IL-2 deficiency reflects a primary T cell defect rather than a macrophage defect. MRL-lpr and B6-lpr spleen cells also have an agedependent reduction in IL-2 response that apparently results from a deficiency of cell surface receptors for IL-2. Congenic MRL-+/+ and B6-+/+ mice, which lack the lpr gene responsible for accelerated autoimmunity and lymphoproliferation, have normal IL-2 activity. These findings suggest that a defect in IL-2 activity may contribute to impaired immunoregulation in mice bearing the lpr gene. The absence of such a defect in MRL-+/+ and B6-+/+ mice further suggests that a single autosomal recessive gene is responsible for the IL-2 deficiency.
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